PIRACETAM-DARNITSA

Psychostimulant and nootropic

learn more

PIRACETAM-DARNITSA

Psychostimulant and nootropic

Indications in adults:

  • symptomatic treatment of psycho-organic syndrome, accompanied by loss of memory, decreased concentration and general activity;
  • treatment of vertigo and related disorders of balance, with the exception of dizziness and vasomotor and mental origin;
  • treatment of cortical myoclonus as monotherapy or in combined therapy;
  • in combined treatment of sickle cell anaemia to reduce the manifestations of the vaso-occlusive crisis.

Indications in children:

  • treatment of dyslexia in children aged over 8 years in combination with other appropriate methods, including speech therapy;
  • treatment of cortical myoclonus as monotherapy or in combined therapy;
  • in combined treatment of sickle cell anaemia in children aged over 3 years to reduce the manifestations of the vaso-occlusive crisis.
More in instructions (Ukrainian version)
INN
Piracetamum
Package
400 mg,30 x 400 mg
Form of release
Tablets
Appointment
Nervous system diseases
АТС class
N06B X03

Other forms of release

  • PIRACETAM-DARNITSA 200 mg, 60 x 200 mg

    PIRACETAM-DARNITSA

See also

  • NEURO-NORM

    20 caps
    NEURO-NORM

    Psychostimulant and nootropic

  • ASCOPHENUM-DARNITSA

    6 tabs
    ASCOPHENUM-DARNITSA

    Combination drug with analgesic, antipyretic and anti-inflammatory effect

  • PIRACETAM-DARNITSA

    200 mg 60 x 200 mg
    PIRACETAM-DARNITSA

    Psychostimulant and nootropicPsychostimulant and nootropic

  • PROSERIN-DARNITSA

    0.5 mg/ml 10 x 1 ml
    PROSERIN-DARNITSA

    Synthetic reversible cholinesterase inhibitor

  • TRIFTAZIN-DARNITSA

    2 mg/ml 10 x 1 ml
    TRIFTAZIN-DARNITSA

    Antipsychotic drug (neuroleptic) iperazine phenothiazine derivative

© 1994 - 2019 Pharmaceutical Firm Darnitsa. All rights reserved.. Terms of Use © 2014 made in uStudio Design
Specialized publications intended for medical institutions and doctors Limitations in obtaining information